Bionano

📍 San Diego, United States👥 189 employees💰 Last funded 2020
Biotechnology Research🌐 bionano.com
Website LinkedIn
Bionano is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. Our mission is to transform the way the world sees the genome through optical genome mapping (OGM) solutions, diagnostic services and software. We offer OGM solutions for applications across basic, translational and clinical research. Bionano also offers an industry-leading, platform-agnostic genome analysis software solution, and nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. Through our Bionano Laboratories business, wey also offer OGM-based diagnostic testing services.
2
Total investors
0
Early stage
0
Mid stage
1
Late stage
—
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Turkey
1
United States
1
Frequently asked questions
Who invested in Bionano?
Bionano has 2 investors on record on gritt.io and 1 late-stage investors.
When did Bionano last raise funding?
The most recent investment in Bionano recorded on gritt.io was in 2020.
What industry is Bionano in?
Bionano operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Bionano based?
Bionano is headquartered in San Diego, United States.